ABVX
Abivax S.A. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +30.0% ·
share flow +30.0% ·
net new positions +20.0%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 83 | +12 | 15.45M | $2.06B | +16 | −3 |
| Q1 2026 | 72 | -1 | 18.00M | $2.00B | +4 | −5 |
| Q4 2025 | 72 | +3 | 22.08M | $2.98B | +3 | — |
| Q3 2025 | 11 | +5 | 9.45M | $802.20M | +5 | — |
| Q2 2025 | 4 | -1 | 2.69M | $20.57M | — | −1 |
| Q1 2025 | 5 | 0 | 2.48M | $15.51M | +1 | −1 |
| Q4 2024 | 5 | -1 | 1.91M | $14.02M | +1 | −2 |
| Q3 2024 | 6 | +1 | 2.23M | $25.72M | +1 | — |
| Q2 2024 | 5 | — | 1.50M | $19.77M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 2.93M | +1642.5% | $248.36M | 0.6% | ▲ Add | 6 | SEC ↗ |
| 2 | Morgan Stanley ✦ | 1.47M | — | $124.86M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 3 | Fidelity (FMR) ✦ | 1.43M | New | $121.46M | 0.0% | New | 1 | SEC ↗ ×3 |
| 4 | Millennium Management ✦ | 1.10M | -12.1% | $93.39M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 5 | Adage Capital Partners ✦ | 977.63K | New | $83.00M | 0.1% | New | 1 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 681.78K | -45.6% | $57.88M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 7 | T. Rowe Price ✦ | 479.87K | New | $40.74M | 0.0% | New | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 189.70K | New | $16.11M | 0.0% | New | 1 | SEC ↗ ×3 |
| 9 | Goldman Sachs Group ✦ | 135.63K | — | $11.51M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passive) | 29.85K | +77.5% | $2.53M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 27.54K | New | $2.34M | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Fidelity (FMR) | $121.46M | 0.0% |
| Adage Capital Partners | $83.00M | 0.1% |
| T. Rowe Price | $40.74M | 0.0% |
| Marshall Wace | $16.11M | 0.0% |
| D. E. Shaw & Co. | $2.34M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 250 holders, 49.39M shares, $5.28B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.